Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Dabigatran Etexilate in Elderly Chinese
NCT05715658Unknown
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dabigatran etexilate oral solution in Atrial fibrillation (AFib) (3 arms). Primary endpoints: Concentration in plasma of dabigatran at 24 hours and Species of intestinal flora. Status: unknown.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05715658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05715658.